focus -WSS

focus

author：fashion 2025-09-30 00:37:08 - browse：7123

Illustration fo a pink arrow pointing downward. -- biotech coverage from STAT — Adobe

SAN DIEGO — Ventyx Biosciences reported on Monday that it was ending development of an experimental drug for treating plaque psoriasis though it proved safe and moderately effective in a mid-stage trial. Within hours, the company’s stock tanked by more than 80%.

That’s because the company announced that the small molecule, VTX958, had not met the biotech’s internal goals to advance to the next phase of clinical development. Ventyx said it would end work on the drug, which targets the signaling molecule TYK2, as a treatment for psoriasis and psoriatic arthritis.

Shares in Ventyx plummeted from $14.09 at market close to as little as $2.72 during after-hours trading. In the process, the company’s market value dropped from $830 million to around $160 million. Ventyx is now trading below its cash balance, which was $300 million as of the end of September.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Blinken talks high

knowledge

WSS

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

‘The Bear’ and hospitality in hospitals

Choosing scientific sides in the fight against Alzheimer's

Travel bans should be based on evidence, not politics or fear

Women's World Cup brings attention to abuse in soccer

One Duchenne patient's bittersweet hope for new treatment

leisure time

focus

explore

After affirmative action ruling, medical educators look to 'holistic review'

An Ebola outbreak presents a new mystery involving children

Malaria cases in Florida and Texas: Here’s what you need to know

Grail's uphill battle for Medicare to cover its cancer screening test

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Astronauts get first look at the spacecraft that will fly them around the moon

How to save PrEP access — and even expand it

The painfully weak evidence on taking collagen to treat arthritis

ChatGPT in medicine: STAT answers readers' burning questions

The debate over Covid

hotspot

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Biden praises World Series champion Astros for impact off the field during White House celebration

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Biden praises World Series champion Astros for impact off the field during White House celebration

Discs beat pads, tampons for heavy menstrual flow, new study shows

An Ebola outbreak presents a new mystery involving children

leisure time

knowledge

Wikipedia

knowledge